NA 176
DIN Standards Committee Health Technologies
Project
Biotechnology - Tumorigenicity assessment - Part 1: General requirements and considerations for testing of cellular therapeutic products
Begin
2025-11-21
Planned document number
ISO/AWI 26125-1
Responsible national committee
NA 176-09-02 AA - Biotechnology